Solid Biosciences logo

Solid Biosciences

SLDB | NASDAQ
Chart Builder DCF Calculator
$6.48
-$0.36 (-5.26%)
At close: Nov 16, 2026, 4:00 PM ET
$6.51
+$0.03 (+0.46%)
After-hours: Nov 16, 2026, 7:50 PM ET
-5.26%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
29.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #829/1021 (Top 81%)

Key Statistics

Market Data

Market Cap $978.69M
1D Range
6.46 6.94
52W Range
4.34 11.15

Valuation (TTM)

PE -3.62
PB 2.86
EV/EBITDA -2.98

Valuation (NTM)

Forward PE N/A
Forward PEG 0.18
Price Target $22.50
Loading financial charts...

Profile

Solid Biosciences Inc. is an American biotechnology firm dedicated to creating therapeutic solutions for Duchenne Muscular Dystrophy (DMD). Its most advanced experimental drug, SGT-001, is a gene tran...

Sector Healthcare
Industry Biotechnology
Employees 121
IPO Date Jan 26, 2018
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
8
Consensus
Buy
Price Target
$22.50
Upside
+247.22%
Buy (8)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.